Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT01866410 · COMPLETED
Trial details
- NCT number
- NCT01866410
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-20
- Primary completion
- 2018-03-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.